Frances Ratangee

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 667 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of <i>Mycobacterium tuberculosis</i> Infection

Elisa Nemes, Virginie Rozot, Hennie Geldenhuys et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 168 citations · Full text

Public Health, Immunology, Infectious Diseases +16

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Thomas J. Scriba, Andrew Fioré-Gartland, Adam Penn‐Nicholson et al. · The Lancet Infectious Diseases · 2021 · 154 citations · Full text

Public Health, Community Health, Preventive Medicine +17

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

Simon C. Mendelsohn, Andrew Fioré-Gartland, Adam Penn‐Nicholson et al. · The Lancet Global Health · 2021 · 50 citations · Full text

Public Health, Community Health, Infectious Diseases +17

H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial

Helen Mearns, Hennie Geldenhuys, Benjamin M. Kagina et al. · Vaccine · 2016 · 42 citations

Veterinary Medicine, Immunology, Infectious Diseases +17